
Mall Staple Claire's U.K. Follows U.S. Parent Into Administration
The U.K. and Ireland operation of accessories retailer Claire's has followed its U.S. parent and collapsed into administration, putting more than 2,150 jobs at risk, after it failed to find a suitable buyer.
The move comes just days after the group's U.S. operations filed for Chapter 11 bankruptcy in a Delaware court earlier this month, blaming increased competition, shifting consumer spending habits, the ongoing move away from bricks-and-mortar retail and debt obligations for its travails.
It was the second time in seven years that the chain has filed for bankruptcy. It said within the filing that the company has debts of between $1 billion and $10 billion.
Canadian affiliate operating stores (Claire's Canada) also intends to commence proceedings in Canada under the Companies' Creditors Arrangement Act in the Ontario Superior Court of Justice.
Claire's retail stores in North America will continue to trade while the company 'explores all strategic alternatives', according to a statement issued by parent company Claire's Holdings LLC and Claire's U.S., which operates Claire's in the U.S.
Claire's U.K. Appoints Administrators
In Britain the retailer appointed Will Wright and Chris Pole from Interpath as joint administrators for its U.K. and European Services businesses yesterday and Claire's, which is headquartered in Birmingham, trades from 306 stores across the U.K. and Ireland.
Interpath U.K. Chief Executive Will Wright said in the announcement: 'Claire's has long been a popular brand across the U.K., known not only for its trend-led accessories but also as the go-to destination for ear piercing. Over the coming weeks, we will endeavour to continue to operate all stores as a going concern for as long as we can, while we assess options for the company. This includes exploring the possibility of a sale which would secure a future for this well-loved brand.'
While Claire's stores will continue to operate as usual, customers will no longer be able to buy items online or seek refunds for purchases made prior to the administration. Orders that have not been dispatched are expected to be cancelled.
The new comes after the business had been working with Interpath in recent weeks to draw up a rescue plan and sound out potential investors willing to salvage all or parts of its British operations, which posted a pre-tax loss of $5.4 million in the year to 3 February 2024. It is also facing an outstanding loan of $482 million that must be repaid in December next year.
Claire's Hit By New Competitors
A once-ubiquitous mall brand widely known for sparkly accessories and ear-piercing kiosks, Claire's downfall has stemmed from a perfect storm. Years of heavy borrowing left the company burdened by debt and as mall foot traffic dwindled, Claire's struggled to pivot online, allowing upstart digital rivals like Shein, Temu and TikTok, plus Amazon, to capture spend from trend-hungry and cost conscious teens.
Adding to the financial challenges, tariffs and supply chain disruptions have pushed up costs, squeezing already thin margins. Even after rent deferrals and interest payment pauses, liquidity dried up and Claire's story in many ways reflects the broader decline of mall-based teen culture brands which have found themselves outpaced by faster, cheaper, and more digitally savvy competitors.
Whether this latest restructuring will save the chain or mark its final chapter remains uncertain.
Claire's, which also trades under the Icing fascia, is owned by a consortium including Elliott Management and Monarch Alternative Capital.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
16 minutes ago
- Yahoo
Hudbay Minerals (HBM) Climbs 15% on Stellar Earnings, $600-Million Investment From Mitsubishi
We recently published . Hudbay Minerals Inc. (NYSE:HBM) is one of the best-performing stocks on Wednesday. Hudbay Minerals grew its share prices for a second day on Wednesday, up 15.03 percent to close at $11.33 apiece, following an impressive earnings performance and a $600-million investment from Mitsubishi Corp. In its updated report, Hudbay Minerals Inc. (NYSE:HBM) said it swung to a net income attributable to shareholders of $117.7 million from an attributable net loss of $16.5 million in the same period last year, driven by higher gross margins and strong cost control. Revenues increased by 26 percent to $536.4 million from $425.5 million year-on-year. 'With the strong performance in the first half of the year, we are reaffirming our full year consolidated production guidance and are favourably tracking well below our full year consolidated cost guidance for 2025,' said Hudbay Minerals Inc. (NYSE:HBM) President and CEO Peter Kukielski. For the full-year period, the company is targeting to produce between 117,000 and 149,000 tons of copper, as well as 247,500 to 308,000 ounces of gold. In other news, Hudbay Minerals Inc. (NYSE:HBM) was able to raise $600 million in fresh funds from Mitsubishi Corp. after the latter acquired a 30-percent stake in Copper World LLC. Under the agreement, Mitsubishi will pay an upfront cash of $420 million, with the balance to serve as a matching contribution within an 18-month period. While we acknowledge the potential of HBM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 minutes ago
- Yahoo
Paramount Skydance (PSKY) Soars 60% to New High. Time to Book Gains?
We recently published . Paramount Skydance Corp. (NASDAQ:PSKY) is one of the best-performing stocks on Wednesday. Paramount Skydance extended its rally to touch a new high on Wednesday, finishing up by 36.74 percent at $15 apiece, with a former hedge fund manager calling it a 'meme' stock. In a social media post, Mad Money host and former hedge fund manager Jim Cramer said Paramount Skydance Corp. (NASDAQ:PSKY) is a 'meme stock' given the company's small public float and unjustifiable rally amid the lack of fresh developments. Paramount Skydance Corp. (NASDAQ:PSKY) climbed by as high as 60 percent at intra-day trading to hit $17.53 before paring gains to finish slightly lower during the session. In recent news, the company bagged a new $7.7-billion deal to exclusively air the Ultimate Fighting Championship (UFC) on Paramount+ for seven years beginning in 2026. The deal would include UFC's full slate of 13 marquee numbered events and 30 Fight Nights through its direct-to-consumer streaming platform, Paramount+, with select numbered events to be simulcast on CBS. cellanr, CC BY-SA 2.0 , via Wikimedia Commons As part of the agreement, Paramount Skydance Corp. (NASDAQ:PSKY) will move UFC away from the existing Pay-Per-View model and make the latter available at no additional cost to Paramount+ subscribers in the US. It also intends to explore UFC rights outside the US in the future. While we acknowledge the potential of PSKY as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 minutes ago
- Yahoo
ImmunityBio (IBRX) Jumps 14% as on Promising Therapy Candidate Results
We recently published . ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best-performing stocks on Wednesday. ImmunityBio soared by 14.17 percent on Wednesday to close at $2.82 apiece as investors cheered promising early findings from its ongoing trial (QUILT-106) to treat a rare blood cancer type with its therapy candidate. In a statement, ImmunityBio, Inc. (NASDAQ:IBRX) said the first phase of QUILT-106 showed highly promising results in the first two patients with Waldenstrom macroglobulinemia (WM)—a type of non-Hodgkins lymphoma (NHL)—using its CD19 CAR-NK (CD19 t-haNK) natural killer cell therapy. The trial aims to evaluate the safety and efficacy of the cell therapy alone, as well as when it is combined with an existing drug called rituximab. According to ImmunityBio, Inc. (NASDAQ:IBRX), both patients tolerated the therapy candidate without any significant side effects. Notably, all infusions were administered in an outpatient setting. Copyright: katrintimoff / 123RF Stock Photo 'One patient achieved a complete response (CR) with CD19 CAR NK monotherapy, while the second patient achieved CR with CD19 CAR-NK in combination with rituximab. Remission was maintained and is ongoing for six months to date,' ImmunityBio, Inc. (NASDAQ:IBRX) said. While we acknowledge the potential of IBRX as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data